Publications by authors named "L Delhaye"

Cancer cells effectively evade immune surveillance, not only through the well-known PD-1/PD-L1 pathway but also alternative mechanisms that impair patient response to immune checkpoint inhibitors. We present a novel co-culture model that pairs a reporter T-cell line with different melanoma cell lines that have varying immune evasion characteristics. We developed a scalable high-throughput lentiviral arrayed CRISPR interference (CRISPRi) screening protocol to conduct gene perturbations in both T-cells and melanoma cells, enabling the identification of genes that modulate tumor immune evasion.

View Article and Find Full Text PDF
Article Synopsis
  • Human myxovirus resistance 2 (MX2) inhibits HIV-1 and herpesviruses post-entry by interacting with viral capsids.
  • Researchers identified that MX2 interacts with numerous FG-rich proteins and forms multiprotein condensates essential for its antiviral activity.
  • These condensates trap the viral capsids and disrupt their entry into the nucleus, effectively preventing the viruses from delivering their genomes into host cells.
View Article and Find Full Text PDF

Protein-protein interactions play an important biological role in every aspect of cellular homeostasis and functioning. Proximity labeling mass spectrometry-based proteomics overcomes challenges typically associated with other methods and has quickly become the current state of the art in the field. Nevertheless, tight control of proximity-labeling enzymatic activity and expression levels is crucial to accurately identify protein interactors.

View Article and Find Full Text PDF

Exogenous glucocorticoids are frequently used to treat inflammatory disorders and as adjuncts for the treatment of solid cancers. However, their use is associated with severe side effects and therapy resistance. Novel glucocorticoid receptor (GR) ligands with a patient-validated reduced side effect profile have not yet reached the clinic.

View Article and Find Full Text PDF

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Owing to a lack of effective treatments, patients with metastatic disease have a median survival time of 6-12 months. We recently demonstrated that the Survival Associated Mitochondrial Melanoma Specific Oncogenic Non-coding RNA is essential for UM cell survival and that antisense oligonucleotide (ASO)-mediated silencing of impaired cell viability and tumor growth and .

View Article and Find Full Text PDF